Scientists question NIH project’s use of 20th century technology to make a universal flu vaccine
$500 million NIH program to make vaccines against pathogens that can trigger pandemics uses approach pioneered in last century
When word broke this week that the Department of Health and Human Services was investing half-a-billion dollars on a National Institutes of Health project to develop a vaccine platform for pathogens that could trigger pandemics, a number of scientists who work in the field of vaccinology had decidedly mixed feelings.
That HHS and NIH are going to continue to invest in efforts to make vaccines that could reduce the impact of future pandemics was good news, many thought. But why spend so much money on using whole killed viruses — an approach pioneered in the last century — as the basis of the vaccines?
